Image

Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors

Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.

Eligibility

Inclusion Criteria:

  • Adults aged 18 and older
  • Self-identified Black women with a history of breast cancer
    • "Self-identified Black woman" refers to individuals who personally identify as a Black or African American woman, inclusive of cisgender women from diverse cultural backgrounds. This will be confirmed during a verbal eligibility screening conducted prior to enrollment
  • Completed active breast cancer treatment (e.g., surgery, chemotherapy, or radiation)

    at least one month prior to enrollment; survivors receiving long-term hormonal therapy are also eligible

  • Reside within the Mayo Clinic Florida catchment area
  • Have access to a smartphone or willingness to use alternative access points
    • "Alternative access points" refer to non-clinical settings through which participants may be made aware of the study, including support groups, community health events, churches, and partner organizations that engage with breast cancer survivors outside of the traditional healthcare setting

Exclusion Criteria:

  • Individuals without a history of breast cancer
  • Those unable to provide verbal consent
  • Individuals who lack the ability to engage with digital platforms, as determined during the screening process via brief questions assessing comfort and experience with mobile technology. Participants must be able to open the app, read content, and complete survey independently. iPads will be available for participants who do not have their own mobile device

Study details
    Breast Carcinoma

NCT07126522

Mayo Clinic

2 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.